Abbreviated venetoclax with decitabine or azacitidine in acute myeloid leukemia

Leuk Res. 2023 Nov:134:107370. doi: 10.1016/j.leukres.2023.107370. Epub 2023 Aug 16.
No abstract available

Keywords: AML; Hypomethylating agent; IDH1; IDH2; Toxicity; Venetoclax.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Azacitidine* / therapeutic use
  • Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
  • Decitabine / therapeutic use
  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy

Substances

  • Azacitidine
  • Decitabine
  • venetoclax
  • Bridged Bicyclo Compounds, Heterocyclic